180 related articles for article (PubMed ID: 23092517)
21. Histone deacetylase inhibitor givinostat: the small-molecule with promising activity against therapeutically challenging haematological malignancies.
Ganai SA
J Chemother; 2016 Aug; 28(4):247-54. PubMed ID: 27121910
[TBL] [Abstract][Full Text] [Related]
22. Hematological malignancies and pregnancy: treat or no treat during first trimester.
Avilés A; Neri N; Nambo MJ
Int J Cancer; 2012 Dec; 131(11):2678-83. PubMed ID: 22511239
[TBL] [Abstract][Full Text] [Related]
23. Modulation of multidrug resistance (MDR) in hematological malignancies.
Covelli A
Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
[TBL] [Abstract][Full Text] [Related]
24. Author response: Precise staging of lymphoma duringpregnancy using MRI is not always crucial.
Lavi N; Horowitz NA; Brenner B
Womens Health (Lond); 2015 Mar; 11(2):103-4. PubMed ID: 25776283
[No Abstract] [Full Text] [Related]
25. Drug therapy for neoplastic disease in adults.
Votaw ML; Bull FE
Med Clin North Am; 1969 Nov; 53(6):1265-78. PubMed ID: 4900716
[No Abstract] [Full Text] [Related]
26. Hematological malignancy and pregnancy: a single-institution experience of 21 cases.
Dilek I; Topcu N; Demir C; Bay A; Uzun K; Gul A; Faik Oner A; Ugras S
Clin Lab Haematol; 2006 Jun; 28(3):170-6. PubMed ID: 16706933
[TBL] [Abstract][Full Text] [Related]
27. B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management.
Rogers BB
Clin J Oncol Nurs; 2020 Apr; 24(2):199-204. PubMed ID: 32196006
[TBL] [Abstract][Full Text] [Related]
28. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
[No Abstract] [Full Text] [Related]
29. Present status and perspectives regarding the therapeutic strategy for acute myeloid leukemia, non-Hodgkin's lymphoma and multiple myeloma in the elderly.
Ohta M
Geriatr Gerontol Int; 2009 Jun; 9(2):115-23. PubMed ID: 19740353
[TBL] [Abstract][Full Text] [Related]
30. Is chemotherapy during the first trimester of pregnancy really safe?
Han SN; Gziri MM; Van Calsteren K; Amant F
Int J Cancer; 2013 Apr; 132(7):1728. PubMed ID: 22945483
[No Abstract] [Full Text] [Related]
31. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
Weingart O; Rehan FA; Schulz H; Naumann F; Knauel I; Bohlius CB; Engert A
J Natl Cancer Inst; 2007 Sep; 99(17):E1. PubMed ID: 17728205
[No Abstract] [Full Text] [Related]
32. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
33. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
Sommer S
Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
[No Abstract] [Full Text] [Related]
34. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
35. Author's reply: Chemotherapy during first trimester of pregnancy.
Avilés A; Neri N; Nambo MJ
Int J Cancer; 2013 Apr; 132(7):1729. PubMed ID: 23015469
[No Abstract] [Full Text] [Related]
36. [Hematologic neoplasms and pregnancy].
Tartas N; Chacón R; Sánchez Avalos JC
Medicina (B Aires); 1995; 55(2):155-8. PubMed ID: 7565054
[TBL] [Abstract][Full Text] [Related]
37. Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks.
Horowitz NA; Lavi N; Nadir Y; Brenner B
Thromb Haemost; 2016 Sep; 116(4):613-7. PubMed ID: 27465578
[TBL] [Abstract][Full Text] [Related]
38. The present status of cancer chemotherapy.
Krakoff IH
Med Clin North Am; 1971 May; 55(3):683-701. PubMed ID: 4102661
[No Abstract] [Full Text] [Related]
39. Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.
; Ustaalioglu BB; Gumus M; Unal A; Cayir K; Sever O; Bilici A; Elkiran ET; Karaca H; Benekli M; Karaoglu A; Seker M
Int J Gynecol Cancer; 2010 Jul; 20(5):698-703. PubMed ID: 20973261
[TBL] [Abstract][Full Text] [Related]
40. New developments with bortezomib in treating multiple myeloma.
Reddy GK
Clin Lymphoma; 2004 Mar; 4(4):215-6. PubMed ID: 15072611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
